BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Birds Will Flock To Your Birdbath When You Plant These Two Flowers Around It - 2Surprise! Saturn's huge moon Titan may not have a buried ocean after all
- 3Palestinians protest against Israel's new death penalty law
- 4Authorities Bust Camel Booze Smuggling Operation, Seize Nearly 2,000 Containers of Illegal Alcohol
- 5Public mistrust linked to drop in deceased donor organ donations and kidney transplants
- Inflammatory Merz remarks on migrants' violence against women slammed
- Nurturing Hacks: Shrewdness from Experienced Mothers and Fathers
- Practice environmental safety in Style: Divulging Famous Electric Vehicle Brands
- Creative Style: 10 Architects Reclassifying the Business
- The Tiny Channel Island With 65 Residents That Chefs And Foodies Go Out Of Their Way To Visit
- Politics at the table? Drinking the wine you brought? An etiquette expert's Thanksgiving dos and don'ts.
- Eat Well, Live Well: An Extensive Manual for Smart dieting and Sustenance
- Rick Steves' Favorite Time To Visit Spain Has Lower Prices And Fewer Crowds
- Record-breaking flu hospitalizations in New York in a single week: Health officials
